openPR Logo
Press release

Antacids Market Analysis 2023: Market Segments, Regional Insights, Key Trends And Forecast To 2032 | GlaxoSmithKline PLC., Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd., and AstraZeneca PLC

08-01-2023 09:32 AM CET | Health & Medicine

Press release from: The Business research company

Antacids Market

Antacids Market

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Antacids Global Market Report 2023 identifies Poor lifestyle choices as the major driver for the Antacids market's growth in the forecast period. The elderly Poor lifestyle choices involve deskbound jobs, poor quality of sleep, and irregular dietary habits, which result in an increase in the acidity level of the stomach and lead to gastroesophageal reflux disease. According to the American College of Gastroenterology, around 60 million Americans suffer from gastroesophageal reflux disease. This drives the demand for antacids.

The global antacids market size will grow from $9.19 billion in 2022 to $9.56 billion in 2023 at a compound annual growth rate (CAGR) of 4.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global antacids market size is expected to grow to $10.65 billion in 2027 at a CAGR of 2.7%.

Download Free Sample Of Antacids Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=2415&type=smp

Major competitors in the Antacids market are GlaxoSmithKline PLC., Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd., and AstraZeneca PLC.

A key trend in the Antacids market includes Mouth-melting antacid. Antacids were available in tablet, liquid, and powder form until now; however, researchers have now come up with mouth-melting antacids which are made up of micro-mouth melting granules that easily melt in the mouth. These granules present in the antacids act in the form of effervescent. An example of a mouth-melting instant relief antacid is Sunpharma's 'Pepmelt', which integrates the effects of herbal constituents present in it with the contemporary mouth-melting technology.

Read More On The Global Antacids Market Report Here:
https://www.thebusinessresearchcompany.com/report/antacids-global-market-report

The Antacids market is segmented -

1. By Drug Class: Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents.
2. Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels.
3. By Formulation Type: Tablet, Liquid, Powder, Other Formulation Types
4. By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Antacids market.

The Business Research Company's "Global Antacids Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Antacids Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2415

The Table Of Content For The Antacids Market Include:

1. Executive Summary
2. Antacids Market Characteristics
3. Antacids Market Trends And Strategies
4. Antacids Market - Macro Economic Scenario
5. Antacids Market Size And Growth
……
27. Antacids Market Competitive Landscape And Company Profiles
28. Antacids Pipeline Analysis
29. Key Mergers And Acquisitions In The Antacids Market
30. Antacids Market Future Outlook and Potential Analysis
31. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antacids Market Analysis 2023: Market Segments, Regional Insights, Key Trends And Forecast To 2032 | GlaxoSmithKline PLC., Pfizer Inc., Bayer AG, Dr. Reddy's Laboratories Ltd., and AstraZeneca PLC here

News-ID: 3151021 • Views:

More Releases from The Business research company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Antacids

Mouth-Melting Antacids Revolutionize The Market Industry Trends Gaining Momentum …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Antacids Market Through 2025? In the past few years, the size of the antacids market has demonstrably increased. It is projected to rise from $9.54 billion in 2024 to $9.9 billion in 2025, with a compound annual growth rate (CAGR) of 3.8%.
Antacids Tablets Market Future Prediction Report By 2033
The Antacids Tablets Market was valued at USD 6.92 billion in 2023, and it is projected to reach USD 12.01 billion by 2033, growing at a CAGR of 5.8% from 2024 to 2033. Antacids Tablets Market Overview The Antacids Tablets Market is experiencing steady growth due to the rising prevalence of acid reflux, indigestion, and gastrointestinal disorders across the globe. Increasing consumption of fast food, stressful lifestyles, and higher awareness about digestive
Rising Incidence Of Acidity Due To Unhealthy Lifestyles Boosts Antacids Market: …
The Antacids Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Antacids Market Size and Projected Growth Rate? The market for antacids has experienced consistent growth in the past few years. The market's value is predicted to escalate from $9.54 billion in 2024 to
North America Antacids Market Prospects and Growth Assessment 2027
The North America antacids market is expected to reach US$ 3,564.22 million in 2027 from US$ 2,684.67 million in 2019. The market is estimated to grow with a CAGR of 3.7% from 2020-2027. The Report North America Antacids Market study by "Business Market Insights" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and
Antacids Market Growth Size, Share |Trend 2030
Exclusive Report by Ameco Research: Antacids Market Size Projected to Reach USD 10 Billion by 2030, Growing at 4.40% CAGR Ameco Research is proud to announce the launch of its latest market research report, Antacids Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research reports to
Antacids Market- In-depth Analysis, Business Strategies, and Growth Rate
The global Antacids market is estimated to attain a valuation of US$12,857.3 mn by the end of 2025, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.1% during the forecast period, 2017 - 2025. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of